Press Release: Kiadis Pharma : Delisting of Kiadis will be effective on 25 May 2021
This is a joint press release by Sanofi Foreign Participations B.V. (the Offeror), Sanofi...
Read full article »
Kiadis Pharma is a biopharmaceutical company that develops and commercializes T-cell based immunotherapies for the treatment of blood cancer.
Read more